- Identify and drive referrals to high value specialists
- Quality Bonuses for specialists who follow Clinical Guidelines and utilize biosimilars
- Develop risk carveouts for key disease states
ACO REACH
Right Patient, Right Drug
Software, care navigation, and risk/financial solutions for instant savings in ACO REACH.
Clinically Validated to Lower Part B Drug Costs
Enter # of ACO beneficiaries:
Potential savings:
$7,700,000
Unmanaged
Outpatient
HOPD
Part B Drug Cost
ACO Risk:
$13.6M
CuraFi Managed
Part B Drug Cost
Outpatient
Outpatient/Home
Biosimilars
Convert to Part D
ACO Risk:
$5.9M
Are you leaving money on the table?
Get a savings report unique to your group and free 30-minute consultation with CuraFi experts.
Free of charge
Secure & confidential
1-week turnaround
Reward Specialists for High Value Care
Activate In-Office Infusions, Risk-Free
- Turnkey services for any PCP or Specialist office to do infusions or injectables
- Centralized Drug purchasing, patient scheduling, and logistics
- Inventory entirely financed so Provider is not at financial risk for the drug
Real Time Visibility into Ongoing Part B Drug Risk
- Software forecasts potential risks to ACO as new drugs come to market
- Anticipate prescribing behavior of specialists and KOLs in any geography
- Updated clinical evidence, FDA labels, etc. for Drugs in Parts B and D
Mitigate the Financial Impact of 200+ Expensive Drugs
Osteoporosis
Diabetic Retinopathy
Age-related Macular Degeneration
Diabetic macular edema
Endocrine/GLP-1
Psoriasis
Dementia & Alzheimer’s Disease
Crohn’s Disease & Ulcerative Colitis